Dare Bioscience Inc (DARE) — Capital Reinvestment Ratio

Latest as of December 2025: 0.14x

Dare Bioscience Inc (DARE) has a Capital Reinvestment Ratio of 0.14x as of December 2025, meaning it reinvests 0% of its operating cash flow ($1.44 Million) in capital expenditures ($206.64K). Check Dare Bioscience Inc (DARE) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.14x
Capex / Operating Cash Flow

Operating Cash Flow

$1.44 Million
USD

Capital Expenditures

$206.64K
USD

Data as of

Dec 2025
Most recent filing

Dare Bioscience Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks Dare Bioscience Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see DARE cash generation efficiency.

Annual Capital Reinvestment Ratio for Dare Bioscience Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for Dare Bioscience Inc from 2024 to 2024. See Dare Bioscience Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.11x $5.39 Million $573.05K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow